Advertisement
Screener

IBIO, INC. (IBIO) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

1.8 / 5 stars · 30/82 Roast Me

IBIO, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

IBIO, INC. (IBIO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.37 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.

Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-28

  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $420.00K.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $377.00K, a 1.89% increase year-over-year.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $253.00K, a 46.74% decline year-over-year.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $323.00K, a 22.17% decline year-over-year.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $1.37M, a 10.26% decline from fiscal 2025.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.53M, a 24.93% decline from fiscal 2024.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $2.04M, a 53.59% decline from fiscal 2023.
  • IBIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $4.39M, a 0.32% increase from fiscal 2022.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed
2026-06-30$420.00K
derived: 10-K 12 month − 3 quarters · filed 2026-08-28
$797.00K
derived: sum of 2 quarters · filed 2026-08-28
$1.05M
derived: sum of 3 quarters · filed 2026-08-28
$1.37M
10-K · filed 2026-08-28
2026-03-31$377.00K
10-Q · filed 2026-05-12
$630.00K
derived: sum of 2 quarters · filed 2026-05-12
$953.00K
derived: sum of 3 quarters · filed 2026-05-12
2025-12-31$253.00K
10-Q · filed 2026-05-12
$576.00K
derived: sum of 2 quarters · filed 2026-05-12
2025-09-30$323.00K
10-Q · filed 2026-05-12
2025-06-30$1.53M
10-K · filed 2026-08-28
2025-03-31$370.00K
10-Q · filed 2026-05-12
$845.00K
derived: sum of 2 quarters · filed 2026-05-12
$1.26M
derived: sum of 3 quarters · filed 2026-05-12
2024-12-31$475.00K
10-Q · filed 2026-05-12
$890.00K
derived: sum of 2 quarters · filed 2026-05-12
2024-09-30$415.00K
10-Q · filed 2026-05-12
2024-06-30$2.04M
10-K · filed 2025-09-05
2024-03-31$457.00K
10-Q · filed 2025-05-02
$913.00K
derived: sum of 2 quarters · filed 2025-05-02
$1.68M
derived: sum of 3 quarters · filed 2025-05-02
2023-12-31$456.00K
10-Q · filed 2025-05-02
$1.22M
derived: sum of 2 quarters · filed 2025-05-02
2023-09-30$765.00K
10-Q · filed 2025-05-02
2023-06-30$4.39M
10-K/A · filed 2024-09-24
2023-03-31$1.60M
10-Q · filed 2024-05-13
$2.72M
derived: sum of 2 quarters · filed 2024-05-13
$3.94M
derived: sum of 3 quarters · filed 2024-05-13
2022-12-31$1.13M
10-Q · filed 2024-05-13
$2.35M
derived: sum of 2 quarters · filed 2024-05-13
2022-09-30$1.22M
10-Q · filed 2024-05-13
2022-06-30$4.38M
10-K · filed 2023-09-27
2022-03-31$1.27M
10-Q · filed 2023-05-15
$2.38M
derived: sum of 2 quarters · filed 2023-05-19
$3.20M
derived: sum of 3 quarters · filed 2023-05-19
2021-12-31$1.10M
10-Q/A · filed 2023-05-19
$1.92M
derived: sum of 2 quarters · filed 2023-05-19
2021-09-30$821.00K
10-Q/A · filed 2023-05-19
2021-06-30$1.59M
10-K · filed 2022-10-11
2021-03-31$374.00K
10-Q · filed 2022-05-12
$639.00K
derived: sum of 2 quarters · filed 2022-05-12
$990.00K
derived: sum of 3 quarters · filed 2022-05-12
2020-12-31$265.00K
10-Q · filed 2022-05-12
$616.00K
derived: sum of 2 quarters · filed 2022-05-12
2020-09-30$351.00K
10-Q · filed 2022-05-12
2020-06-30$388.00K
10-K · filed 2021-09-28
2020-03-31$63.00K
10-Q · filed 2021-05-17
$100.00K
derived: sum of 2 quarters · filed 2021-05-17
$168.00K
derived: sum of 3 quarters · filed 2021-05-17
2019-12-31$37.00K
10-Q · filed 2021-05-17
$105.00K
derived: sum of 2 quarters · filed 2021-05-17
2019-09-30$68.00K
10-Q · filed 2021-05-17
2019-06-30$241.00K
10-K · filed 2020-10-13
2019-03-31$49.00K
10-Q · filed 2020-05-15
$109.00K
derived: sum of 2 quarters · filed 2020-05-15
$182.00K
derived: sum of 3 quarters · filed 2020-05-15
$375.00K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$60.00K
10-Q · filed 2020-05-15
$133.00K
10-Q · filed 2019-02-13
$326.00K
derived: sum of 3 quarters · filed 2020-05-15
$509.00K
derived: sum of 4 quarters · filed 2020-05-15
2018-09-30$73.00K
10-Q · filed 2020-05-15
$266.00K
derived: sum of 2 quarters · filed 2020-05-15
$449.00K
derived: sum of 3 quarters · filed 2020-05-15
$638.00K
derived: sum of 4 quarters · filed 2020-05-15
2018-06-30$193.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26
$376.00K
derived: sum of 2 quarters · filed 2019-08-26
$565.00K
derived: sum of 3 quarters · filed 2019-08-26
$770.00K
10-K · filed 2019-08-26
2018-03-31$183.00K
10-Q · filed 2019-05-10
$372.00K
derived: sum of 2 quarters · filed 2019-05-10
$577.00K
10-Q · filed 2018-05-11
$874.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$189.00K
10-Q · filed 2019-05-10
$394.00K
10-Q · filed 2018-02-14
$691.00K
derived: sum of 3 quarters · filed 2019-05-10
$898.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-09-30$205.00K
10-Q · filed 2019-05-10
$502.00K
derived: sum of 2 quarters · filed 2019-05-10
$709.00K
derived: sum of 3 quarters · filed 2019-05-10
$950.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-06-30$297.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18
$504.00K
derived: sum of 2 quarters · filed 2018-09-18
$745.00K
derived: sum of 3 quarters · filed 2018-09-18
$1.01M
10-K · filed 2018-09-18
2017-03-31$207.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15
$448.00K
derived: sum of 2 quarters · filed 2017-05-15
$713.00K
10-Q · filed 2017-05-15
$1.02M
derived: sum of 4 quarters · filed 2017-09-15
2016-12-31$241.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-21
$506.00K
10-Q · filed 2017-02-21
$811.00K
derived: sum of 3 quarters · filed 2017-09-15
$1.11M
derived: sum of 4 quarters · filed 2017-09-15
2016-09-30$265.00K
10-Q · filed 2016-11-18
$570.00K
derived: sum of 2 quarters · filed 2017-09-15
$867.00K
derived: sum of 3 quarters · filed 2017-09-15
$1.18M
derived: sum of 4 quarters · filed 2017-09-15
2016-06-30$305.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15
$602.00K
derived: sum of 2 quarters · filed 2017-09-15
$916.00K
derived: sum of 3 quarters · filed 2017-09-15
$1.25M
10-K · filed 2017-09-15
2016-03-31$297.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23
$611.00K
derived: sum of 2 quarters · filed 2016-05-23
$940.00K
10-Q · filed 2016-05-23
$1.16M
derived: sum of 4 quarters · filed 2016-10-13
2015-12-31$314.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-22
$643.00K
10-Q · filed 2016-02-22
$867.00K
derived: sum of 3 quarters · filed 2016-10-13
$1.09M
derived: sum of 4 quarters · filed 2016-10-13
2015-09-30$329.00K
10-Q · filed 2015-11-13
$553.00K
derived: sum of 2 quarters · filed 2016-10-13
$777.00K
derived: sum of 3 quarters · filed 2016-10-13
$990.00K
derived: sum of 4 quarters · filed 2016-10-13
2015-06-30$224.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13
$448.00K
derived: sum of 2 quarters · filed 2016-10-13
$661.00K
derived: sum of 3 quarters · filed 2016-10-13
$914.00K
10-K · filed 2016-10-13
2015-03-31$224.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15
$437.00K
derived: sum of 2 quarters · filed 2015-05-15
$690.00K
10-Q · filed 2015-05-15
$930.00K
derived: sum of 4 quarters · filed 2015-10-13
2014-12-31$213.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-24
$466.00K
10-Q · filed 2015-02-24
$706.00K
derived: sum of 3 quarters · filed 2015-10-13
$1.03M
derived: sum of 4 quarters · filed 2015-10-13
2014-09-30$253.00K
10-Q · filed 2014-11-14
$493.00K
derived: sum of 2 quarters · filed 2015-10-13
$818.00K
derived: sum of 3 quarters · filed 2015-10-13
2014-06-30$240.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13
$565.00K
derived: sum of 2 quarters · filed 2015-10-13
$1.07M
10-K · filed 2015-10-13
2014-03-31$325.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15
$835.00K
10-Q · filed 2014-05-15
2013-12-31$510.00K
10-Q · filed 2014-02-14
2013-06-30$1.26M
10-K · filed 2014-09-29
2012-12-31$216.80K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-19
$670.40K
10-Q · filed 2013-02-19
$1.35M
derived: sum of 3 quarters · filed 2013-10-04
$1.96M
derived: sum of 4 quarters · filed 2013-10-04
2012-09-30$453.60K
10-Q · filed 2012-11-14
$1.13M
derived: sum of 2 quarters · filed 2013-10-04
$1.74M
derived: sum of 3 quarters · filed 2013-10-04
$2.73M
derived: sum of 4 quarters · filed 2013-10-04
2012-06-30$676.70K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04
$1.29M
derived: sum of 2 quarters · filed 2013-10-04
$2.27M
derived: sum of 3 quarters · filed 2013-10-04
$2.61M
10-K/A · filed 2013-10-04
$2.61M
10-K/A · filed 2012-10-15
2012-03-31$611.95K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15
$1.60M
derived: sum of 2 quarters · filed 2012-05-15
$1.94M
10-Q · filed 2012-05-15
2011-12-31$985.06K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14
$1.32M
10-Q · filed 2012-02-14
2011-09-30$338.29K
10-Q · filed 2011-11-14
2011-06-30$3.90M
10-K/A · filed 2012-10-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
Lifevantage Corp (LFVN)United States$0.078B15.40
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41